Evidence map›Paper›PMID 34345241›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2021

Successful treatment of plasmapheresis followed by interferon beta-1a in a child with severe COVID-19.

Rana Saleh, Hamid Rahimi, Amin Dehghan, Atefeh Sadeghizadeh, Alaleh Gheisari, Shima Saeidi, Zahra Pourmoghaddas

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rana SalehDepartment of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Hamid RahimiDepartment of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Amin DehghanStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Atefeh SadeghizadehDepartment of Pediatric Intensive Care, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Alaleh GheisariDepartment of Pediatric Nephrology Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Shima SaeidiDepartment of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra PourmoghaddasDepartment of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Weatherford College · USIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 outbreak has become a global health concern due to challenges in treatment and high mortality rate; therefore, its therapeutic approaches play an important role in reducing the mortality rate and resolving this concern. Different therapies have been introduced, including interferon beta-1a and purification methods, for instance, plasmapheresis. In this article, we reported a child with severe COVID-19 who fully recovered after receiving plasmapheresis and interferon beta-1a.

Indexed as

COVID-19interferon beta-1apediatric infectious diseaseplasmapheresis

Identifiers

PMID34345241
PMCPMC8305773
OpenAlexW3187956303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.